Primary Site >> Pancreatic Cancer

Gene >> MAL2

Journal: Cancer Res. 2009 Jul 15;69(14):5820-8.
Title: Epithelial to mesenchymal transition contributes to drug resistance in pancreatic cancer.
Author: Arumugam, Thiruvengadam|Ramachandran, Vijaya|Fournier, Keith F|Wang, Huamin|Marquis, Lauren|Abbruzzese, James L|Gallick, Gary E|Logsdon, Craig D|McConkey, David J|Choi, Woonyoung
PMID: 19584296
Journal: Nucl Med Biol. 2013 Jul;40(5):606-17.
Title: 177Lu-labeled HPMA copolymers utilizing cathepsin B and S cleavable linkers: synthesis, characterization and preliminary in vivo investigation in a pancreatic cancer model.
Author: Ogbomo, Sunny M|Shi, Wen|Wagh, Nilesh K|Zhou, Zhengyuan|Brusnahan, Susan K|Garrison, Jered C
PMID: 23622691
Journal: Surgery. 2013 Sep;154(3):573-82.
Title: MAL2 expression predicts distant metastasis and short survival in pancreatic cancer.
Author: Eguchi, Daiki|Ohuchida, Kenoki|Kozono, Shingo|Ikenaga, Naoki|Shindo, Koji|Cui, Lin|Fujiwara, Kenji|Akagawa, Shin|Ohtsuka, Takao|Takahata, Shunichi|Tokunaga, Shoji|Mizumoto, Kazuhiro|Tanaka, Masao
PMID: 23876361